Spring is here, and it's time to start building momentum for VeloSano 5! Remember, a ll of the funds raised through VeloSano support cancer research right here in Cleveland. 

Getting involved is easy. Your help and support is appreciated:

• Join Team Case CCC as a rider from the 12 to 200-mile level. Case CCC Director, Dr. Stan Gerson, will be on the 100-mile route, and looks  forward to riding with you!
• Raise funds as a virtual rider  on Team Case CCC by signing up and supporting all of us!
• Join as a volunteer to help before and during the ride to keep us on track, hydrated and cheered on!
• Come to team events and show your support: Happy Hours scheduled for the following times: 
  Thur, May 10, 4-6p, Washington Place
  Thurs, May 24, 4-6p, TOLI
  Thurs, June 7, 4-6p, Washington Place 
  Fri, June 29, 5-8p, TOLI

May 11, 12-1p | BRB 105

Join us Friday, May 11 at noon in the Biomedical Research Building Frohring Auditorium (BRB 105) for a special  Cancer Center Seminar Series , to hear Nicolaus Kröger, MD, Professor of Medicine and Medical Director of the Department of Stem Cell Transplantation at the University Medical Center Hamburg-Eppendorf , discuss " Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma in 2018 ."

Dr. Kröger's research interest is on stem cell biology and stem cell transplantation, the detection and treatment of minimal residual disease by adoptive immunotherapy or novel drugs, the impact of NK-cell allo-reactivity, optimizing outcome with HLA-mismatched donor, and prevention and treatment of chronic graft-versus-host disease.

From 2006 to 2012, Dr. Kröger served as chairman of the MDS subcommittee of the European Group for Blood and Marrow Transplantation (EBMT), and since 2012 he has been chairman of the Chronic Malignancies Working Party and board member of EBMT, and since 2014 also the chairman of the Scientific Council of EBMT. In 2018 he was elected as President of EBMT (2018-2022).

Dr. Kröger is also chairman of the German Stem Cell Working Group (DAG-KBT) and member of several editorial boards such as Blood, Haematologica and Bone Marrow Transplantation. He is also a member of the Scientific Program Committee and the Editorial Board of the European Hematology Association (EHA) and member of the Scientific Committee of the European School for Hematology (ESH). Additional memberships include societies such as the American Society of
Hematology (ASH), European Hematology Association (EHA), European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO) , the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) and the International Myeloma Working Group (IMWG).

Dr. Mikkael Sekeres  is director of the leukemia program at the  Cleveland Clinic, and Deputy Associate Director for Clinical Research and Director for Clinical Trials, Case Comprehensive Cancer Center. 

Deadline: Aug 28, 2018

National and international nominations are being sought for the  2019 Harrington Prize for Innovation in Medicine , which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. 

The Harrington Prize, which carries a $20,000 honorarium, is a collaboration between The American Society for Clinical Investigation (ASCI), one of the nation's oldest and most respected medical honor societies, and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio-part of The Harrington Project for Discovery & Development. The Harrington Discovery Institute is a nonprofit institute dedicated to supporting physician-scientists, and all scientists in areas of unmet therapeutic need, in their work to transform discoveries into medicines for the benefit of society.